The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug middlemen are marking up the prices of specialty generic drugs dispensed at their ...

The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

See: FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%. Also read: UnitedHealthcare head Brian Thompson's killing shines light on health-insurance denial rates.

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

A proposed Arkansas law would forbid pharmacy benefit managers (PBMs) from holding or acquiring interest in retail pharmacy ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.